| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| DVA - DaVita HealthCare Partners Inc | SELL | -50 @ USD 145.77 | USD -7,289 | The ETF sold 50 shares of DVA on 2025-05-20. The shares were previously bought for an average price of USD 154.347. The DaVita HealthCare Partners Inc shares were sold for -5.6% lower than average price of previous purchases. This resulted in an overall loss of USD 429 The average price that the ETF previously sold DVA share for is USD 153.421 which is higher than the selling price of USD 145.77 on 2025-05-20. |
| CRL - Creightons Plc | SELL | -56 @ USD 143.53 | USD -8,038 | The ETF sold 56 shares of CRL on 2025-05-20. The shares were previously bought for an average price of USD 168.232. The Creightons Plc shares were sold for -14.7% lower than average price of previous purchases. This resulted in an overall loss of USD 1,383 The average price that the ETF previously sold CRL share for is USD 188.508 which is higher than the selling price of USD 143.53 on 2025-05-20. |
| TECH - Bio-Techne Corp | SELL | -174 @ USD 49.53 | USD -8,618 | The ETF sold 174 shares of TECH on 2025-05-20. The shares were previously bought for an average price of USD 65.0058. The Bio-Techne Corp shares were sold for -23.8% lower than average price of previous purchases. This resulted in an overall loss of USD 2,693 The average price that the ETF previously sold TECH share for is USD 70.4928 which is higher than the selling price of USD 49.53 on 2025-05-20. |
| HSIC - Henry Schein Inc | SELL | -138 @ USD 73.13 | USD -10,092 | The ETF sold 138 shares of HSIC on 2025-05-20. The shares were previously bought for an average price of USD 72.8322. The Henry Schein Inc shares were sold for 0.4% higher than average price of previous purchases. This sale made a profit of USD 41 The average price that the ETF previously sold HSIC share for is USD 71.0968 so the ETF has sold 138 shares on 2025-05-20 at a higher price than the previous selling average. |
| MRNA - Moderna Inc | SELL | -368 @ USD 27.99 | USD -10,300 | The ETF sold 368 shares of MRNA on 2025-05-20. The shares were previously bought for an average price of USD 35.3915. The Moderna Inc shares were sold for -20.9% lower than average price of previous purchases. This resulted in an overall loss of USD 2,724 The average price that the ETF previously sold MRNA share for is USD 41.5135 which is higher than the selling price of USD 27.99 on 2025-05-20. |
| SOLV - Solventum Corp. | SELL | -148 @ USD 74.7 | USD -11,056 | The ETF sold 148 shares of SOLV on 2025-05-20. The shares were previously bought for an average price of USD 74.1474. The Solventum Corp. shares were sold for 0.7% higher than average price of previous purchases. This sale made a profit of USD 82 The average price that the ETF previously sold SOLV share for is USD 70.2523 so the ETF has sold 148 shares on 2025-05-20 at a higher price than the previous selling average. |
| INCY - Incyte Corporation | SELL | -178 @ USD 65.3 | USD -11,623 | The ETF sold 178 shares of INCY on 2025-05-20. The shares were previously bought for an average price of USD 69.0067. The Incyte Corporation shares were sold for -5.4% lower than average price of previous purchases. This resulted in an overall loss of USD 660 The average price that the ETF previously sold INCY share for is USD 72.453 which is higher than the selling price of USD 65.3 on 2025-05-20. |
| VTRS - Viatris Inc | SELL | -1,336 @ USD 8.88 | USD -11,864 | The ETF sold 1336 shares of VTRS on 2025-05-20. The shares were previously bought for an average price of USD 10.3985. The Viatris Inc shares were sold for -14.6% lower than average price of previous purchases. This resulted in an overall loss of USD 2,029 The average price that the ETF previously sold VTRS share for is USD 12.124 which is higher than the selling price of USD 8.88 on 2025-05-20. |
| UHS - Universal Health Services Inc | SELL | -62 @ USD 195.73 | USD -12,135 | The ETF sold 62 shares of UHS on 2025-05-20. The shares were previously bought for an average price of USD 189.072. The Universal Health Services Inc shares were sold for 3.5% higher than average price of previous purchases. This sale made a profit of USD 413 The average price that the ETF previously sold UHS share for is USD 192.677 so the ETF has sold 62 shares on 2025-05-20 at a higher price than the previous selling average. |
| RVTY - Revvity Inc. | SELL | -136 @ USD 93.58 | USD -12,727 | The ETF sold 136 shares of RVTY on 2025-05-20. The shares were previously bought for an average price of USD 111.979. The Revvity Inc. shares were sold for -16.4% lower than average price of previous purchases. This resulted in an overall loss of USD 2,502 The average price that the ETF previously sold RVTY share for is USD 113.683 which is higher than the selling price of USD 93.58 on 2025-05-20. |
| HOLX - Hologic Inc | SELL | -248 @ USD 56.47 | USD -14,005 | The ETF sold 248 shares of HOLX on 2025-05-20. The shares were previously bought for an average price of USD 66.9002. The Hologic Inc shares were sold for -15.6% lower than average price of previous purchases. This resulted in an overall loss of USD 2,587 The average price that the ETF previously sold HOLX share for is USD 72.1072 which is higher than the selling price of USD 56.47 on 2025-05-20. |
| ALGN - Align Technology Inc | SELL | -78 @ USD 182.58 | USD -14,241 | The ETF sold 78 shares of ALGN on 2025-05-20. The shares were previously bought for an average price of USD 188.268. The Align Technology Inc shares were sold for -3.0% lower than average price of previous purchases. This resulted in an overall loss of USD 444 The average price that the ETF previously sold ALGN share for is USD 215.059 which is higher than the selling price of USD 182.58 on 2025-05-20. |
| WST - West Pharmaceutical Services Inc | SELL | -78 @ USD 215.43 | USD -16,804 | The ETF sold 78 shares of WST on 2025-05-20. The shares were previously bought for an average price of USD 256.3. The West Pharmaceutical Services Inc shares were sold for -15.9% lower than average price of previous purchases. This resulted in an overall loss of USD 3,188 The average price that the ETF previously sold WST share for is USD 303.686 which is higher than the selling price of USD 215.43 on 2025-05-20. |
| BAX - Baxter International Inc | SELL | -560 @ USD 31.46 | USD -17,618 | The ETF sold 560 shares of BAX on 2025-05-20. The shares were previously bought for an average price of USD 33.3208. The Baxter International Inc shares were sold for -5.6% lower than average price of previous purchases. This resulted in an overall loss of USD 1,042 The average price that the ETF previously sold BAX share for is USD 32.4172 which is higher than the selling price of USD 31.46 on 2025-05-20. |
| COO - The Cooper Companies, Inc. Common Stock | SELL | -224 @ USD 81.5 | USD -18,256 | The ETF sold 224 shares of COO on 2025-05-20. The shares were previously bought for an average price of USD 89.0886. The The Cooper Companies, Inc. Common Stock shares were sold for -8.5% lower than average price of previous purchases. This resulted in an overall loss of USD 1,700 The average price that the ETF previously sold COO share for is USD 95.9458 which is higher than the selling price of USD 81.5 on 2025-05-20. |
| MOH - MOH | SELL | -60 @ USD 326.15 | USD -19,569 | The ETF sold 60 shares of MOH on 2025-05-20. The shares were previously bought for an average price of USD 309.477. The MOH shares were sold for 5.4% higher than average price of previous purchases. This sale made a profit of USD 1,000 The average price that the ETF previously sold MOH share for is USD 306.539 so the ETF has sold 60 shares on 2025-05-20 at a higher price than the previous selling average. |
| MOH - LVMH Moët Hennessy - Louis Vuitton Société Européenne | SELL | -60 @ USD 326.15 | USD -19,569 | The ETF sold 60 shares of MOH on 2025-05-20. The shares were previously bought for an average price of USD 309.477. The LVMH Moët Hennessy - Louis Vuitton Société Européenne shares were sold for 5.4% higher than average price of previous purchases. This sale made a profit of USD 1,000 The average price that the ETF previously sold MOH share for is USD 306.539 so the ETF has sold 60 shares on 2025-05-20 at a higher price than the previous selling average. |
| ZBH - Zimmer Biomet Holdings Inc | SELL | -218 @ USD 95.35 | USD -20,786 | The ETF sold 218 shares of ZBH on 2025-05-20. The shares were previously bought for an average price of USD 107.101. The Zimmer Biomet Holdings Inc shares were sold for -11.0% lower than average price of previous purchases. This resulted in an overall loss of USD 2,562 The average price that the ETF previously sold ZBH share for is USD 107.248 which is higher than the selling price of USD 95.35 on 2025-05-20. |
| BIIB - Biogen Inc | SELL | -160 @ USD 130.55 | USD -20,888 | The ETF sold 160 shares of BIIB on 2025-05-20. The shares were previously bought for an average price of USD 145.643. The Biogen Inc shares were sold for -10.4% lower than average price of previous purchases. This resulted in an overall loss of USD 2,415 The average price that the ETF previously sold BIIB share for is USD 157.437 which is higher than the selling price of USD 130.55 on 2025-05-20. |
| DGX - Quest Diagnostics Incorporated | SELL | -124 @ USD 178.24 | USD -22,102 | The ETF sold 124 shares of DGX on 2025-05-20. The shares were previously bought for an average price of USD 167.015. The Quest Diagnostics Incorporated shares were sold for 6.7% higher than average price of previous purchases. This sale made a profit of USD 1,392 The average price that the ETF previously sold DGX share for is USD 159.633 so the ETF has sold 124 shares on 2025-05-20 at a higher price than the previous selling average. |
| LH - Laboratory Corporation of America Holdings | SELL | -90 @ USD 250.8 | USD -22,572 | The ETF sold 90 shares of LH on 2025-05-20. The shares were previously bought for an average price of USD 241.284. The Laboratory Corporation of America Holdings shares were sold for 3.9% higher than average price of previous purchases. This sale made a profit of USD 856 The average price that the ETF previously sold LH share for is USD 236.074 so the ETF has sold 90 shares on 2025-05-20 at a higher price than the previous selling average. |
| WAT - Waters Corporation | SELL | -64 @ USD 362.1 | USD -23,174 | The ETF sold 64 shares of WAT on 2025-05-20. The shares were previously bought for an average price of USD 369.261. The Waters Corporation shares were sold for -1.9% lower than average price of previous purchases. This resulted in an overall loss of USD 458 The average price that the ETF previously sold WAT share for is USD 372.181 which is higher than the selling price of USD 362.1 on 2025-05-20. |
| WAT - MULETFWATIMETFP | SELL | -64 @ USD 362.1 | USD -23,174 | The ETF sold 64 shares of WAT on 2025-05-20. The shares were previously bought for an average price of USD 369.261. The MULETFWATIMETFP shares were sold for -1.9% lower than average price of previous purchases. This resulted in an overall loss of USD 458 The average price that the ETF previously sold WAT share for is USD 372.181 which is higher than the selling price of USD 362.1 on 2025-05-20. |
| PODD - Insulet Corporation | SELL | -76 @ USD 327.47 | USD -24,888 | The ETF sold 76 shares of PODD on 2025-05-20. The shares were previously bought for an average price of USD 268.184. The Insulet Corporation shares were sold for 22.1% higher than average price of previous purchases. This sale made a profit of USD 4,506 The average price that the ETF previously sold PODD share for is USD 263.128 so the ETF has sold 76 shares on 2025-05-20 at a higher price than the previous selling average. |
| MTD - Mettler-Toledo International Inc | SELL | -22 @ USD 1186 | USD -26,092 | The ETF sold 22 shares of MTD on 2025-05-20. The shares were previously bought for an average price of USD 1239.38. The Mettler-Toledo International Inc shares were sold for -4.3% lower than average price of previous purchases. This resulted in an overall loss of USD 1,174 The average price that the ETF previously sold MTD share for is USD 1238.17 which is higher than the selling price of USD 1186 on 2025-05-20. |
| MTD - AMUNDI EUR GOV 710 | SELL | -22 @ USD 1186 | USD -26,092 | The ETF sold 22 shares of MTD on 2025-05-20. The shares were previously bought for an average price of USD 1239.38. The AMUNDI EUR GOV 710 shares were sold for -4.3% lower than average price of previous purchases. This resulted in an overall loss of USD 1,174 The average price that the ETF previously sold MTD share for is USD 1238.17 which is higher than the selling price of USD 1186 on 2025-05-20. |
| IQV - IQVIA Holdings Inc | SELL | -184 @ USD 144.95 | USD -26,671 | The ETF sold 184 shares of IQV on 2025-05-20. The shares were previously bought for an average price of USD 191.616. The IQVIA Holdings Inc shares were sold for -24.4% lower than average price of previous purchases. This resulted in an overall loss of USD 8,587 The average price that the ETF previously sold IQV share for is USD 196.899 which is higher than the selling price of USD 144.95 on 2025-05-20. |
| STE - STERIS plc | SELL | -108 @ USD 250.47 | USD -27,051 | The ETF sold 108 shares of STE on 2025-05-20. The shares were previously bought for an average price of USD 222.089. The STERIS plc shares were sold for 12.8% higher than average price of previous purchases. This sale made a profit of USD 3,065 The average price that the ETF previously sold STE share for is USD 215.518 so the ETF has sold 108 shares on 2025-05-20 at a higher price than the previous selling average. |
| HUM - Hummingbird Resources PLC | SELL | -132 @ USD 255.31 | USD -33,701 | The ETF sold 132 shares of HUM on 2025-05-20. The shares were previously bought for an average price of USD 270.038. The Hummingbird Resources PLC shares were sold for -5.5% lower than average price of previous purchases. This resulted in an overall loss of USD 1,944 The average price that the ETF previously sold HUM share for is USD 276.774 which is higher than the selling price of USD 255.31 on 2025-05-20. |
| HUM - Humana Inc | SELL | -132 @ USD 255.31 | USD -33,701 | The ETF sold 132 shares of HUM on 2025-05-20. The shares were previously bought for an average price of USD 270.038. The Humana Inc shares were sold for -5.5% lower than average price of previous purchases. This resulted in an overall loss of USD 1,944 The average price that the ETF previously sold HUM share for is USD 276.774 which is higher than the selling price of USD 255.31 on 2025-05-20. |
| CNC - Concurrent Technologies Plc | SELL | -552 @ USD 61.96 | USD -34,202 | The ETF sold 552 shares of CNC on 2025-05-20. The shares were previously bought for an average price of USD 60.1182. The Concurrent Technologies Plc shares were sold for 3.1% higher than average price of previous purchases. This sale made a profit of USD 1,017 The average price that the ETF previously sold CNC share for is USD 60.0634 so the ETF has sold 552 shares on 2025-05-20 at a higher price than the previous selling average. |
| A - Agilent Technologies Inc | SELL | -314 @ USD 113.48 | USD -35,633 | The ETF sold 314 shares of A on 2025-05-20. The shares were previously bought for an average price of USD 128.911. The Agilent Technologies Inc shares were sold for -12.0% lower than average price of previous purchases. This resulted in an overall loss of USD 4,845 The average price that the ETF previously sold A share for is USD 132.384 which is higher than the selling price of USD 113.48 on 2025-05-20. |
| GEHC - GE HealthCare Technologies Inc. | SELL | -502 @ USD 71.85 | USD -36,069 | The ETF sold 502 shares of GEHC on 2025-05-20. The shares were previously bought for an average price of USD 84.8343. The GE HealthCare Technologies Inc. shares were sold for -15.3% lower than average price of previous purchases. This resulted in an overall loss of USD 6,518 The average price that the ETF previously sold GEHC share for is USD 81.1608 which is higher than the selling price of USD 71.85 on 2025-05-20. |
| DXCM - DexCom Inc | SELL | -432 @ USD 87.34 | USD -37,731 | The ETF sold 432 shares of DXCM on 2025-05-20. The shares were previously bought for an average price of USD 77.8843. The DexCom Inc shares were sold for 12.1% higher than average price of previous purchases. This sale made a profit of USD 4,085 The average price that the ETF previously sold DXCM share for is USD 75.6596 so the ETF has sold 432 shares on 2025-05-20 at a higher price than the previous selling average. |
| RMD - ResMed Inc | SELL | -162 @ USD 248.14 | USD -40,199 | The ETF sold 162 shares of RMD on 2025-05-20. The shares were previously bought for an average price of USD 234.22. The ResMed Inc shares were sold for 5.9% higher than average price of previous purchases. This sale made a profit of USD 2,255 The average price that the ETF previously sold RMD share for is USD 240.07 so the ETF has sold 162 shares on 2025-05-20 at a higher price than the previous selling average. |
| CAH - Cardinal Health Inc | SELL | -266 @ USD 154.77 | USD -41,169 | The ETF sold 266 shares of CAH on 2025-05-20. The shares were previously bought for an average price of USD 128.331. The Cardinal Health Inc shares were sold for 20.6% higher than average price of previous purchases. This sale made a profit of USD 7,033 The average price that the ETF previously sold CAH share for is USD 122.625 so the ETF has sold 266 shares on 2025-05-20 at a higher price than the previous selling average. |
| IDXX - IDEXX Laboratories Inc | SELL | -88 @ USD 517.16 | USD -45,510 | The ETF sold 88 shares of IDXX on 2025-05-20. The shares were previously bought for an average price of USD 440.802. The IDEXX Laboratories Inc shares were sold for 17.3% higher than average price of previous purchases. This sale made a profit of USD 6,720 The average price that the ETF previously sold IDXX share for is USD 428.043 so the ETF has sold 88 shares on 2025-05-20 at a higher price than the previous selling average. |
| EW - Edwards Lifesciences Corp | SELL | -648 @ USD 77.83 | USD -50,434 | The ETF sold 648 shares of EW on 2025-05-20. The shares were previously bought for an average price of USD 71.2794. The Edwards Lifesciences Corp shares were sold for 9.2% higher than average price of previous purchases. This sale made a profit of USD 4,245 The average price that the ETF previously sold EW share for is USD 70.3802 so the ETF has sold 648 shares on 2025-05-20 at a higher price than the previous selling average. |
| COR - Cencora Inc. | SELL | -188 @ USD 292.93 | USD -55,071 | The ETF sold 188 shares of COR on 2025-05-20. The shares were previously bought for an average price of USD 254.646. The Cencora Inc. shares were sold for 15.0% higher than average price of previous purchases. This sale made a profit of USD 7,197 The average price that the ETF previously sold COR share for is USD 246.393 so the ETF has sold 188 shares on 2025-05-20 at a higher price than the previous selling average. |
| BDX - Becton Dickinson and Company | SELL | -314 @ USD 176.67 | USD -55,474 | The ETF sold 314 shares of BDX on 2025-05-20. The shares were previously bought for an average price of USD 226.588. The Becton Dickinson and Company shares were sold for -22.0% lower than average price of previous purchases. This resulted in an overall loss of USD 15,674 The average price that the ETF previously sold BDX share for is USD 223.343 which is higher than the selling price of USD 176.67 on 2025-05-20. |
| REGN - Regeneron Pharmaceuticals Inc | SELL | -114 @ USD 614.79 | USD -70,086 | The ETF sold 114 shares of REGN on 2025-05-20. The shares were previously bought for an average price of USD 704.506. The Regeneron Pharmaceuticals Inc shares were sold for -12.7% lower than average price of previous purchases. This resulted in an overall loss of USD 10,228 The average price that the ETF previously sold REGN share for is USD 747.942 which is higher than the selling price of USD 614.79 on 2025-05-20. |
| HCA - HCA Holdings Inc | SELL | -194 @ USD 386.05 | USD -74,894 | The ETF sold 194 shares of HCA on 2025-05-20. The shares were previously bought for an average price of USD 337.989. The HCA Holdings Inc shares were sold for 14.2% higher than average price of previous purchases. This sale made a profit of USD 9,324 The average price that the ETF previously sold HCA share for is USD 327.42 so the ETF has sold 194 shares on 2025-05-20 at a higher price than the previous selling average. |
| ZTS - Zoetis Inc | SELL | -488 @ USD 163.65 | USD -79,861 | The ETF sold 488 shares of ZTS on 2025-05-20. The shares were previously bought for an average price of USD 167.219. The Zoetis Inc shares were sold for -2.1% lower than average price of previous purchases. This resulted in an overall loss of USD 1,742 The average price that the ETF previously sold ZTS share for is USD 171.513 which is higher than the selling price of USD 163.65 on 2025-05-20. |
| CVS - CVS Health Corp | SELL | -1,376 @ USD 63.74 | USD -87,706 | The ETF sold 1376 shares of CVS on 2025-05-20. The shares were previously bought for an average price of USD 62.9223. The CVS Health Corp shares were sold for 1.3% higher than average price of previous purchases. This sale made a profit of USD 1,125 The average price that the ETF previously sold CVS share for is USD 55.3848 so the ETF has sold 1376 shares on 2025-05-20 at a higher price than the previous selling average. |
| CI - Cigna Corp | SELL | -298 @ USD 325 | USD -96,850 | The ETF sold 298 shares of CI on 2025-05-20. The shares were previously bought for an average price of USD 316.767. The Cigna Corp shares were sold for 2.6% higher than average price of previous purchases. This sale made a profit of USD 2,453 The average price that the ETF previously sold CI share for is USD 312.73 so the ETF has sold 298 shares on 2025-05-20 at a higher price than the previous selling average. |
| MCK - McKesson Corporation | SELL | -136 @ USD 719.19 | USD -97,810 | The ETF sold 136 shares of MCK on 2025-05-20. The shares were previously bought for an average price of USD 621.578. The McKesson Corporation shares were sold for 15.7% higher than average price of previous purchases. This sale made a profit of USD 13,275 The average price that the ETF previously sold MCK share for is USD 602.75 so the ETF has sold 136 shares on 2025-05-20 at a higher price than the previous selling average. |
| ELV - Elevance Health Inc | SELL | -252 @ USD 412.49 | USD -103,947 | The ETF sold 252 shares of ELV on 2025-05-20. The shares were previously bought for an average price of USD 410.75. The Elevance Health Inc shares were sold for 0.4% higher than average price of previous purchases. This sale made a profit of USD 438 The average price that the ETF previously sold ELV share for is USD 401.774 so the ETF has sold 252 shares on 2025-05-20 at a higher price than the previous selling average. |
| ELV - Elevance Health Inc | SELL | -252 @ USD 412.49 | USD -103,947 | The ETF sold 252 shares of ELV on 2025-05-20. The shares were previously bought for an average price of USD 410.75. The Elevance Health Inc shares were sold for 0.4% higher than average price of previous purchases. This sale made a profit of USD 438 The average price that the ETF previously sold ELV share for is USD 401.774 so the ETF has sold 252 shares on 2025-05-20 at a higher price than the previous selling average. |
| BMY - Bloomsbury Publishing Plc | SELL | -2,214 @ USD 47.87 | USD -105,984 | The ETF sold 2214 shares of BMY on 2025-05-20. The shares were previously bought for an average price of USD 57.3147. The Bloomsbury Publishing Plc shares were sold for -16.5% lower than average price of previous purchases. This resulted in an overall loss of USD 20,911 The average price that the ETF previously sold BMY share for is USD 56.4136 which is higher than the selling price of USD 47.87 on 2025-05-20. |
| MDT - Medtronic PLC | SELL | -1,398 @ USD 86.37 | USD -120,745 | The ETF sold 1398 shares of MDT on 2025-05-20. The shares were previously bought for an average price of USD 88.7467. The Medtronic PLC shares were sold for -2.7% lower than average price of previous purchases. This resulted in an overall loss of USD 3,323 The average price that the ETF previously sold MDT share for is USD 85.3824 so the ETF has sold 1398 shares on 2025-05-20 at a higher price than the previous selling average. |
| VRTX - Vertex Pharmaceuticals Inc | SELL | -278 @ USD 447.18 | USD -124,316 | The ETF sold 278 shares of VRTX on 2025-05-20. The shares were previously bought for an average price of USD 478.652. The Vertex Pharmaceuticals Inc shares were sold for -6.6% lower than average price of previous purchases. This resulted in an overall loss of USD 8,749 The average price that the ETF previously sold VRTX share for is USD 463.522 which is higher than the selling price of USD 447.18 on 2025-05-20. |
| DHR - Danaher Corporation | SELL | -696 @ USD 197.77 | USD -137,648 | The ETF sold 696 shares of DHR on 2025-05-20. The shares were previously bought for an average price of USD 216.682. The Danaher Corporation shares were sold for -8.7% lower than average price of previous purchases. This resulted in an overall loss of USD 13,163 The average price that the ETF previously sold DHR share for is USD 231.086 which is higher than the selling price of USD 197.77 on 2025-05-20. |
| DHR - Danaher Corporation | SELL | -696 @ USD 197.77 | USD -137,648 | The ETF sold 696 shares of DHR on 2025-05-20. The shares were previously bought for an average price of USD 216.682. The Danaher Corporation shares were sold for -8.7% lower than average price of previous purchases. This resulted in an overall loss of USD 13,163 The average price that the ETF previously sold DHR share for is USD 231.086 which is higher than the selling price of USD 197.77 on 2025-05-20. |
| PFE - Pfizer Inc | SELL | -6,174 @ USD 23.52 | USD -145,212 | The ETF sold 6174 shares of PFE on 2025-05-20. The shares were previously bought for an average price of USD 25.8066. The Pfizer Inc shares were sold for -8.9% lower than average price of previous purchases. This resulted in an overall loss of USD 14,117 The average price that the ETF previously sold PFE share for is USD 25.9088 which is higher than the selling price of USD 23.52 on 2025-05-20. |
| SYK - Stryker Corporation | SELL | -374 @ USD 389.55 | USD -145,692 | The ETF sold 374 shares of SYK on 2025-05-20. The shares were previously bought for an average price of USD 379.729. The Stryker Corporation shares were sold for 2.6% higher than average price of previous purchases. This sale made a profit of USD 3,673 The average price that the ETF previously sold SYK share for is USD 374.972 so the ETF has sold 374 shares on 2025-05-20 at a higher price than the previous selling average. |
| GILD - Guild Esports Plc | SELL | -1,356 @ USD 109.11 | USD -147,953 | The ETF sold 1356 shares of GILD on 2025-05-20. The shares were previously bought for an average price of USD 102.991. The Guild Esports Plc shares were sold for 5.9% higher than average price of previous purchases. This sale made a profit of USD 8,297 The average price that the ETF previously sold GILD share for is USD 94.4347 so the ETF has sold 1356 shares on 2025-05-20 at a higher price than the previous selling average. |
| AMGN - Amgen Inc | SELL | -584 @ USD 275.01 | USD -160,606 | The ETF sold 584 shares of AMGN on 2025-05-20. The shares were previously bought for an average price of USD 303.22. The Amgen Inc shares were sold for -9.3% lower than average price of previous purchases. This resulted in an overall loss of USD 16,475 The average price that the ETF previously sold AMGN share for is USD 289.058 which is higher than the selling price of USD 275.01 on 2025-05-20. |
| BSX - Boston Scientific Corporation | SELL | -1,604 @ USD 106.54 | USD -170,890 | The ETF sold 1604 shares of BSX on 2025-05-20. The shares were previously bought for an average price of USD 98.6851. The Boston Scientific Corporation shares were sold for 8.0% higher than average price of previous purchases. This sale made a profit of USD 12,599 The average price that the ETF previously sold BSX share for is USD 90.5857 so the ETF has sold 1604 shares on 2025-05-20 at a higher price than the previous selling average. |
| BSX - MULSTRXSSXIMETFP | SELL | -1,604 @ USD 106.54 | USD -170,890 | The ETF sold 1604 shares of BSX on 2025-05-20. The shares were previously bought for an average price of USD 98.6851. The MULSTRXSSXIMETFP shares were sold for 8.0% higher than average price of previous purchases. This sale made a profit of USD 12,599 The average price that the ETF previously sold BSX share for is USD 90.5857 so the ETF has sold 1604 shares on 2025-05-20 at a higher price than the previous selling average. |
| TMO - Time Out Group plc | SELL | -416 @ USD 413.75 | USD -172,120 | The ETF sold 416 shares of TMO on 2025-05-20. The shares were previously bought for an average price of USD 521.751. The Time Out Group plc shares were sold for -20.7% lower than average price of previous purchases. This resulted in an overall loss of USD 44,928 The average price that the ETF previously sold TMO share for is USD 521.151 which is higher than the selling price of USD 413.75 on 2025-05-20. |
| MRK - Marks Electrical Group PLC | SELL | -2,750 @ USD 77.97 | USD -214,418 | The ETF sold 2750 shares of MRK on 2025-05-20. The shares were previously bought for an average price of USD 91.8712. The Marks Electrical Group PLC shares were sold for -15.1% lower than average price of previous purchases. This resulted in an overall loss of USD 38,228 The average price that the ETF previously sold MRK share for is USD 98.432 which is higher than the selling price of USD 77.97 on 2025-05-20. |
| MRK - Merck & Company Inc | SELL | -2,750 @ USD 77.97 | USD -214,418 | The ETF sold 2750 shares of MRK on 2025-05-20. The shares were previously bought for an average price of USD 91.8712. The Merck & Company Inc shares were sold for -15.1% lower than average price of previous purchases. This resulted in an overall loss of USD 38,228 The average price that the ETF previously sold MRK share for is USD 98.432 which is higher than the selling price of USD 77.97 on 2025-05-20. |
| ISRG - Intuitive Surgical Inc | SELL | -386 @ USD 557.16 | USD -215,064 | The ETF sold 386 shares of ISRG on 2025-05-20. The shares were previously bought for an average price of USD 541.1. The Intuitive Surgical Inc shares were sold for 3.0% higher than average price of previous purchases. This sale made a profit of USD 6,199 The average price that the ETF previously sold ISRG share for is USD 530.933 so the ETF has sold 386 shares on 2025-05-20 at a higher price than the previous selling average. |
| ABT - Abbott Laboratories | SELL | -1,884 @ USD 135.2 | USD -254,717 | The ETF sold 1884 shares of ABT on 2025-05-20. The shares were previously bought for an average price of USD 127.034. The Abbott Laboratories shares were sold for 6.4% higher than average price of previous purchases. This sale made a profit of USD 15,385 The average price that the ETF previously sold ABT share for is USD 117.864 so the ETF has sold 1884 shares on 2025-05-20 at a higher price than the previous selling average. |
| UNH - UnitedHealth Group Incorporated | SELL | -1,000 @ USD 321.58 | USD -321,580 | The ETF sold 1000 shares of UNH on 2025-05-20. The shares were previously bought for an average price of USD 524.136. The UnitedHealth Group Incorporated shares were sold for -38.6% lower than average price of previous purchases. This resulted in an overall loss of USD 202,556 The average price that the ETF previously sold UNH share for is USD 554.662 which is higher than the selling price of USD 321.58 on 2025-05-20. |
| ABBV - AbbVie Inc | SELL | -1,916 @ USD 184.85 | USD -354,173 | The ETF sold 1916 shares of ABBV on 2025-05-20. The shares were previously bought for an average price of USD 193.556. The AbbVie Inc shares were sold for -4.5% lower than average price of previous purchases. This resulted in an overall loss of USD 16,681 The average price that the ETF previously sold ABBV share for is USD 185.054 which is higher than the selling price of USD 184.85 on 2025-05-20. |
| JNJ - Johnson & Johnson | SELL | -2,614 @ USD 153.66 | USD -401,667 | The ETF sold 2614 shares of JNJ on 2025-05-20. The shares were previously bought for an average price of USD 157.979. The Johnson & Johnson shares were sold for -2.7% lower than average price of previous purchases. This resulted in an overall loss of USD 11,290 The average price that the ETF previously sold JNJ share for is USD 152.562 so the ETF has sold 2614 shares on 2025-05-20 at a higher price than the previous selling average. |
| LLY - Eli Lilly and Company | SELL | -854 @ USD 747.01 | USD -637,947 | The ETF sold 854 shares of LLY on 2025-05-20. The shares were previously bought for an average price of USD 837.646. The Eli Lilly and Company shares were sold for -10.8% lower than average price of previous purchases. This resulted in an overall loss of USD 77,403 The average price that the ETF previously sold LLY share for is USD 794.088 which is higher than the selling price of USD 747.01 on 2025-05-20. |